Follow
Brendon E. Cook
Brendon E. Cook
Biogen
Verified email at gradcenter.cuny.edu
Title
Cited by
Cited by
Year
Pretargeted imaging and therapy
M Altai, R Membreno, B Cook, V Tolmachev, BM Zeglis
Journal of Nuclear Medicine 58 (10), 1553-1559, 2017
1792017
Optimization of a pretargeted strategy for the PET imaging of colorectal carcinoma via the modulation of radioligand pharmacokinetics
BM Zeglis, C Brand, D Abdel-Atti, KE Carnazza, BE Cook, S Carlin, ...
Molecular pharmaceutics 12 (10), 3575-3587, 2015
1112015
Pretargeted PET imaging using a site-specifically labeled immunoconjugate
BE Cook, P Adumeau, R Membreno, KE Carnazza, C Brand, T Reiner, ...
Bioconjugate chemistry 27 (8), 1789-1795, 2016
802016
Click-mediated pretargeted radioimmunotherapy of colorectal carcinoma
R Membreno, BE Cook, K Fung, JS Lewis, BM Zeglis
Molecular pharmaceutics 15 (4), 1729-1734, 2018
472018
Dendrimer scaffold for the amplification of in vivo pretargeting ligations
BE Cook, R Membreno, BM Zeglis
Bioconjugate chemistry 29 (8), 2734-2740, 2018
362018
A brief overview of metal complexes as nuclear imaging agents
DS MacPherson, K Fung, BE Cook, LC Francesconi, BM Zeglis
Dalton Transactions 48 (39), 14547-14565, 2019
322019
Toward the optimization of click-mediated pretargeted radioimmunotherapy
R Membreno, OM Keinänen, BE Cook, KM Tully, KC Fung, JS Lewis, ...
Molecular pharmaceutics 16 (5), 2259-2263, 2019
282019
Pretargeted PET of osteodestructive lesions in dogs
CA Maitz, S Delaney, BE Cook, AR Genady, R Hoerres, M Kuchuk, ...
Molecular pharmaceutics 19 (9), 3153-3162, 2022
112022
Non-invasive Imaging of Antisense Oligonucleotides in the Brain via In Vivo Click Chemistry
BE Cook, J Archbold, K Nasr, S Girmay, SI Goldstein, P Li, S Dandapani, ...
Molecular Imaging and Biology 24 (6), 940-949, 2022
82022
Pretargeted radioimmunotherapy based on the inverse electron demand diels-alder reaction
R Membreno, BE Cook, BM Zeglis
JoVE (Journal of Visualized Experiments), e59041, 2019
82019
Removal of Fc Glycans from [89Zr]Zr-DFO-Anti-CD8 Prevents Peripheral Depletion of CD8+ T Cells
JM White, OM Keinänen, BE Cook, BM Zeglis, HM Gibson, NT Viola
Molecular pharmaceutics 17 (6), 2099-2108, 2020
42020
Novel positron-emitting radiopharmaceuticals
M Sarparanta, DW Demoin, BE Cook, JS Lewis, BM Zeglis
Nuclear oncology–from pathophysiology to clinical applications. New York, NY …, 2017
42017
Development of a PET Tracer for OGA with Improved Kinetics in the Living Brain
BE Cook, S Nag, R Arakawa, EYS Lin, N Stratman, K Guckian, H Hering, ...
Journal of Nuclear Medicine 64 (10), 1588-1593, 2023
22023
The synthesis, radiolabeling, and characterization of 177Lu-labeled tetrazine radioligands for pretargeted radioimmunotherapy
R Membreno, J Houghton, B Cook, K Carnazza, J Lewis, B Zeglis
Journal of Nuclear Medicine 57 (supplement 2), 1201-1201, 2016
12016
Discovery of [18F] F-687-TCO: An Optimized Tracer for Pretargeted PET Imaging in the CNS
B Cook, T Pickel, D Jiang, P Bolduc, S Nag, SP Tang, K Nasr, G Boscutti, ...
Nuclear Medicine and Biology 126, 108545, 2023
2023
Trans-cyclooctene labeled antisense oligonucleotides, radio labeled tetrazine and methods
BE Cook, MA Kaliszczak, L Martarello, NE Genung, S Dandapani, ...
US Patent App. 17/636,600, 2022
2022
The optimization of click-mediated pretargeted radioimmunotherapy
R Membreno, B Cook, K Tully, J Lewis, B Zeglis
Nuclear Medicine and Biology 72, S17-S18, 2019
2019
Bifunctional dendrimer scaffold leads to increased tumor uptake
B Cook, R Membreno, B Zeglis
Nuclear Medicine and Biology 72, S16, 2019
2019
Deglycosylated CD8-specific immunoPET probe prevents antibody-mediated depletion of CD8+ immune cells
J White, O KeinÃ, B Cook, B Zeglis, H Gibson, NT Villegas
Journal of Nuclear Medicine 60 (supplement 1), 1002-1002, 2019
2019
An international journal of inorganic chemistry incorporating Acta Chemica Scandinavica
DS MacPherson, K Fung, BE Cook, LC Francesconi, BM Zeglis, J He, X Li, ...
Dalton Trans 48, 14535-14546, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20